Jingchu Net (Hubei Daily Net) News (Reporter Tian Cheng Correspondent Shen Junning) On the morning of September 28, Xianning Central Hospital "In Vitro Fertilization-Embryo Transfer (IVF-ET)" and "Intracytoplasmic Sperm Microscopy" Injection (ICSI)" technology successfully passed the review and assessment of the National Health and Construction Commission's Assisted Reproductive Technology Review Expert Group, and officially became a medical institution with the technical qualification to carry out "test-tube baby".
review site. Correspondent Photo courtesy of
The development of this technology has filled the medical gap in the field of reproductive medicine in Xianning City, marking a new level of reproductive medicine in Xianning City. On the morning of the same day, Wang Dan, Director of the Maternity and Childhood Division of the Hubei Provincial Health and Construction Commission, was the leader of the team. The evaluation expert group Sun Yat-sen Memorial Hospital of Sun Yat-sen UniversityProfessor Zhang Qingxue, the Fourth Affiliated Hospital of Zhejiang University School of MedicineProfessor Xu Jian, and the Second Xiangya University of Central South University Professor Shi Xiaobo from the hospital, Professor Deng Zhaohui from Hunan Maternal and Child Health Hospital, Professor Zhao Shuhua from the First Affiliated Hospital of Kunming Medical University, Professor Jiang Xianglong from Jiangxi Provincial Human Sperm Bank, and Professor Yang Xianfeng from the Third Affiliated Hospital of Zhengzhou University visited our hospital, and the hospital The "In Vitro Fertilization-Embryo Transfer (IVF-ET)" and "Intracytoplasmic Sperm Injection (ICSI)" technologies were formally reviewed on site.
Dong Weifeng, deputy director of the Xianning Municipal Health and Health Commission, attended the evaluation report meeting. Guo Dongsheng, president of the hospital, and Zheng Bo, secretary of the party committee, accompanied the evaluation. At the
review meeting, Xu Lan, the clinical director of the reproductive center of the hospital, reported the basic situation of the center and the preparation of IVF-ET/ICSI to the expert group in detail, and gave an on-site defense to the expert group's questions.
Subsequently, the expert review group was divided into 4 groups: ethics management group, clinical group, andrology group, and laboratory group, focusing on the ethical management, rules and regulations, personnel qualifications, clinical and laboratory operations, clinical medical records, etc. A careful and professional review was carried out, and the site layout, equipment configuration and operation of the center were inspected on the spot.
Wang Dan, director of the Maternity and Children's Division of the Hubei Provincial Health and Construction Commission, made a review summary and announced that the on-site review of the "test tube baby" technology trial project was unanimously passed.
